Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy

Molecular and Biochemical Parasitology

Volumn 117, Issue 1, 2001, Pages 73-81

  Matovu, Enock ^a   Geiser, Federico ^a   Schneider, Vreni ^a   Mäser, Pascal ^b   Enyaru, John C K ^c   Kaminsky, Ronald ^d   Gallati, Sabina ^a   Seebeck, Thomas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Livestock Health Research Institute Uganda   (Uganda)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Adenosine transporter; African trypanosomes; Drug resistance; Human sleeping sickness; Melarsoprol; SSCP

Indexed keywords

ADENOSINE TRANSPORTER; AMINO ACID; CARRIER PROTEIN; MELARSAMINE; MELARSOPROL; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CODON; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RELAPSE; SILENT GENE; TRYPANOSOMA; TRYPANOSOMA BRUCEI; UGANDA;

TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 0034852287     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(01)00332-2     Document Type: Article

References (24)

1. New drugs for the treatment of human African trypanosomiasis: Research and development
2. Current therapy of trypanosomiasis
3. Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis
4. Human sleeping sickness - Current approaches to chemotherapy
5. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-α-difluoromethylornithine (DFMO)
6. An outbreak of relapses among patients treated for Trypanosoma brucei gambiense trypanosomosis in Arua District, Uganda, November 1996 to April 1997
7. Melarsoprol refractory T. b. gambiense from Omugo, North Western Uganda
8. Drug resistance in Trypanosoma brucei Ssp, the causative agents of sleeping sickness in man and nagana in cattle
9. Arsenical-resistant trypanosomes lack an unusual adenosine transporter
10. A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity
11. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: Implications for cross-resistance with arsenicals
12. Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: Substrate recognition motifs and affinity for trypanocidal drugs
13. A nucleoside transporter from Trypanosoma brucei involved in drug resistance
14. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
15. Two buffer PAGE system-based SSCP/HD analysis: A general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease
16. Detecting single base substitutions as heteroduplex polymorphisms
17. Induction of resistance to melarsen oxide cysteamine (Mel Cy) in Trypanosoma brucei brucei
18. Susceptibility of Ugandan Trypanosoma brucei rhodesiense isolated from man and animal reservoirs to diminazene, isometamidium and melarsoprol
19. A kit for in vitro isolation of trypanosomes in the field: First trial with sleeping sickness patients in the Congo Republic
20. Cultivation and in vitro cloning of procyclic culture forms of Trypanosoma brucei in a semi-defined medium
21. Structure and transcription of the actin gene of Trypanosoma brucei
22. Investigations of the metabolites of the trypanocidal drug melarsoprol
23. An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids
24. The treatment of human African trypanosomiasis